Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically

NARecruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

February 9, 2024

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2028

Conditions
HIV Infections
Interventions
OTHER

EPI LOVE

Observational cohort only

Trial Locations (1)

90095

RECRUITING

University of California, Los Angeles, Los Angeles

All Listed Sponsors
collaborator

Florida State University

OTHER

collaborator

University of California, Irvine

OTHER

collaborator

University of North Carolina, Chapel Hill

OTHER

collaborator

AIDS Healthcare Foundation

OTHER

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of California, Los Angeles

OTHER